July 31, 2016 6:56 AM ET

Health Care Technology

Company Overview of Schrödinger, LLC

Company Overview

Schrödinger, LLC provides scientific software solutions and services for life sciences and materials research, as well as academic, government, and non-profit institutions around the world. It offers small-molecule drug discovery, biologics, materials science, and discovery informatics solutions; and PyMOL, a 3D molecular visualization solution. The company was founded in 1990 and is based in Portland, Oregon with operations in the United States, Europe, Japan, and India.

101 S.W. Main Street

Suite 1300

Portland, OR 97204

United States

Founded in 1990

Phone:

503-299-1150

Fax:

503-299-4532

Key Executives for Schrödinger, LLC

President and Director
Co-Founder and Chief Financial Officer
Co-Founder, Scientific Advisory Chairman and Director
Vice President and General Counsel
Managing Director and Executive Vice President
Compensation as of Fiscal Year 2016.

Schrödinger, LLC Key Developments

Schrödinger, Inc. Announces Research Collaboration with Pfizer Inc

Schrödinger Inc. announced that it has entered into a research collaboration agreement with Pfizer Inc., in which the two companies will work together to develop a computational model for predicting key properties relevant to biotherapeutic candidates. In this collaboration, each company will perform tasks in an attempt to develop a novel model for predictions of properties. Pfizer will generate and provide experimental data against which the computational model is to be developed by the Schrödinger team, while teams from both companies will work together to determine future systems of interest to which to apply, test, and further refine the developing technology.

Schrodinger Signs Drug Discovery Collaboration with Sanofi

Schrodinger signed a multi-year early drug discovery collaboration with Sanofi. Under the contract, Schrodinger will offer target analysis and validation to lead identification and lead optimisation for around ten drug discovery programmes. Schrodinger is to receive up to USD 120 million, which includes preclinical milestones. A new enterprise informatics system will also facilitate real-time collaboration between computational designers and medicinal chemists and will serve as the communications and project management platform for researchers across both firms.

Sanofi Signs $120 million Collaboration Agreement with Schrodinger

Sanofi announced it has entered into a collaboration agreement with Schrodinger. Under the agreement, Schrodinger will provide comprehensive computational drug design support for as many as ten drug discovery programs. In return, Sanofi will pay up to $120 million, including pre-clinical milestones.

Similar Private Companies By Industry

Company Name Region
1747, Inc. United States
1EQ, Inc. United States
20over8, Inc. United States
21CT, Inc. United States
3AM Technologies, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
June 29, 2016
Morphic Rock Therapeutic, Inc.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Schrödinger, LLC, please visit www.schrodinger.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.